A virtual copy for each woman with cancer: so is personalized cancer medicine moving forward

by CNIO - Centro Nacional de Investigaciones Oncológicas

The project, still under development, seeks to create 'digital twins' - virtual replicas of patients - that would eventually enable to personalize treatments and to accurately anticipate the evolution...

Read more

Una nueva inmunoterapia para la leucemia linfoblástica aguda de células B, el cáncer pediátrico más frecuente

by CNIO - Centro Nacional de Investigaciones Oncológicas

La inmunoterapia ‘CAR-STAb’ obtiene buenos resultados en modelos animales, gracias en parte a que logra reclutar a más células defensivas del cuerpo para combatir a las células tumorales.

Read more

University of Barcelona Science Park ecosystem holds steady with €124 million in investment in 2024

by Parc Científic de Barcelona

The University of Barcelona Science Park (PCB-UB) solidified its position as a key player in Catalonia’s research and innovation landscape, with its thriving business ecosystem continuing to attract...

Read more

Nuage Therapeutics receives €1.8 million to advance the development of its first oncology therapy targeting intrinsically disordered proteins

by Parc Científic de Barcelona

This financial contribution will enable the Catalan biotech company to advance the development of new drugs targeting therapeutic targets traditionally considered intractable, such as intrinsically di...

Read more

Megaproyecto nacional para mejorar el abordaje de los síndromes mielodisplásicos con la incorporación de la inteligencia artificial y la experiencia de los pacientes

by Instituto de Investigación Biomédica de Salamanca - IBSAL

La hematóloga e investigadora del IBSAL, María Díez Campelo, coordina el proyecto UMBRELLA-SUMMA-LEGACY, que ha logrado una financiación de casi 3,4 millones de euros del ISCIII y en el que partic...

Read more

El Hospital público 12 de Octubre participa en el desarrollo del primer fármaco oral eficaz frente a un cáncer de pulmón que afecta a no fumadores

by Hospital Universitario 12 de Octubre

El ensayo Beamion LUNG-1 ha evaluado Zongertinib en un ensayo de fase 1 en 126 pacientes con cáncer de células no pequeñas avanzado o metastásico con mutación en HER2 distribuidos en diversos gru...

Read more

IBEC receives funding from the prestigious Human Frontier Science Program

by IBEC - Institut de Bioenginyeria de Catalunya

The Institute for Bioengineering of Catalonia (IBEC) is participating in the international SOLFEGE project, which aims to explore how different cell types coordinate with each other through soluble fa...

Read more

Immunotherapy in cancer treatment (and beyond)

by Sermes CRO

Unlike conventional treatments that directly target tumors, immunotherapy aims to boost the patient’s own immune defenses. Think of it as specialized training for your immune system—teaching it to...

Read more

The Clínic Barcelona Comprehensive Cancer Center presents its latest advances at the ASCO 2025 Global Oncology Congress

by Fundació Clínic per a la Recerca Biomèdica

The Clínic Barcelona Comprehensive Cancer Center (4CB), driven by Hospital Clínic, IDIBAPS, and the University of Barcelona, strengthens its international presence with a prominent participation at ...

Read more

Novel targeted therapy in locally aggressive tenosynovial giant cell tumor

by VHIO

The pivotal phase 3 MANEUVER trial is a three-part, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of pimicotinib, an oral, highly selective and potent...

Read more

Thermo Fisher Scientific Unveils Next-generation Mass Spectrometers at ASMS 2025 to Revolutionize Biopharma Applications and Omics Research

by Thermo Fisher Scientific

Orbitrap Astral Zoom and Orbitrap Excedion Pro deliver increased speed and sensitivity to set a new performance benchmark for high-resolution, accurate mass spectrometry

Read more

Desarrollan un método que detecta de manera ultrasensible la enfermedad residual en la sangre de pacientes con mieloma múltiple

by CIBERONC - Centro de Investigación Biomédica en Red, Cáncer

El personal científico concluye que BloodFlow constituye una herramienta innovadora que mejora significativamente la detección de enfermedad residual en sangre periférica y ofrece una evaluación m...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Telum Therapeutics Secures €18 Million...

by Telum Therapeutics

Telum Therapeutics, a biotechnology company leveraging proprietary met...

Photos Stream